-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
-
Summary
-
Ani Pharmaceuticals Inc quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q4 2010 to Q4 2023.
- Ani Pharmaceuticals Inc Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending December 31, 2023 was $2.9M, a 51.6% decline year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)